Cipla informs about Press Release

01 Jun 2015 Evaluate

Cipla has informed about Press Release dated June 01, 2015 titled ‘Stempeutics receives Orphan Drug Designation (ODD) in the European Union for its novel stem cell drug ‘Stempeucel’ for the treatment of Thromboangiitis Obliterans’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1320.35 -7.90 (-0.59%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×